Workflow
GLUCODOWN®
icon
搜索文档
Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its Board of Directors
Globenewswire· 2025-10-29 20:00
BENTONVILLE, Ark., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced a further strengthening of its Board of Directors with the appointment of Christopher J. Jemapete, effective today. Mr. Jemapete was an early strategic investor in Glucose Health, Inc. beginning in 2017 and continues to maintain a substantial equity position in the company. Mr. Jemapete brings three decades of experience in the financial services and securities industry to the Board of Directors of Glucose ...